Glaucoma and the Pandemic: A Surgery-Led Approach
Watch four top glaucoma experts discuss ways to address pandemic-induced delays in care, including risk stratification, remote IOP monitoring, and MIGS options
Aleksandra Jones |
Sat around the virtual table are:
Miriam Kolko, Professor in Translational Eye Research at the University of Copenhagen and chief physician at the Copenhagen University Hospital, Denmark – who moderated the discussion
Anthony Khawaja, Consultant Ophthalmologist at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK
Kaweh Mansouri, glaucoma specialist, Consultant Ophthalmologist at Montchoisi Clinique in Lausanne, Switzerland and Department of Ophthalmology, University of Colorado, Denver, USA
Constance Okeke, glaucoma specialist at Virginia Eye Consultants, Assistant Professor of Ophthalmology, Eastern Virginia Medical School, Norfolk, Virginia, USA
Watch the video to find out:
- How has glaucoma management changed since March 2020? What are specialists doing differently?
- How can delays in care be addressed?
- How can risk stratification help in this?
- What lessons can be learned about the natural history of glaucoma from enforced delayed follow-up?
- Have any innovations or new approaches been helpful in continuing care over the past year or might they be useful in the near future?
- Can telemedicine help manage glaucoma patients remotely?
- What’s your experience with IOP measurement sensors? Telemetric measurement, continuous 24-hour IOP monitoring… has it been useful during the pandemic?
- How is MIGS reducing the need for frequent in-office visits during and after the pandemic?
- How have glaucoma surgical innovations changed in the last few years and what are specialists doing differently?
- Why is patient-centricity such a hot topic in glaucoma management?
- What expectations do you have for short- and long-term future?